In a piece of exhilarating news and the one which would bring relief to the world, Russia has successfully completed the clinical trials of the COVID-19 vaccine.
The clinical human trials of the Russian COVID-19 vaccine in Moscow have been completed and the results have proven the effectiveness of the medicine. Chief researcher Elena Smolyarchuk who heads the center for clinical research on medications at Sechenov University informed the Russian news agency on Sunday about the completion of the vaccine. She said,
“The research has been completed and it proved that the vaccine is safe. The volunteers will be discharged on July 15 and 20.”
Despite this, there was no information revealed regarding the commercial stage of the vaccine. Russia had permitted clinical trials for two forms of COVID-19 vaccine that was developed by the Gamaleya National Research Center for Epidemiology and Microbiology on the 18th of June. While the first vaccine was in the form of a solution for intramuscular administration, the second was in the form of a powder that would later be used to prepare the solution for intramuscular administration. The first one was carried out at Burdenko Military Hospital and the second was done at Sechenov First Moscow State Medical University.
Volunteers Develop Immune Response
The first stage of the vaccine by Sechenov University involved two groups of volunteers. The first group had 18 and the second had 20. Post the vaccination, the volunteers are expected to remain in isolation for a period of 28 days. When the tests were performed on the volunteers, they showed signs of developing immunity to the novel coronavirus. According to an earlier statement by the Russian Defense Ministry,
“The data obtained by the Gamalei National Research Center for Epidemiology and Microbiology proves that volunteers of the first and second groups are forming an immune response after injections of the vaccine against the coronavirus.”
So far, Russia has reported over 719,449 confirmed cases of COVID-19 with a death toll touching 11,188. According to the World Health Organisation, there are at least 21 vaccines of COVID-19 that are under an important stage of trials. That includes the Indian vaccine developed by Bharat Biotech which has been promised to be out by the 15 of August by the Indian Council of Medical Research.
Source: The Times of India
